Structure

Physi-Chem Properties

Molecular Weight:  324.14
Volume:  342.876
LogP:  4.729
LogD:  3.992
LogS:  -3.558
# Rotatable Bonds:  4
TPSA:  66.76
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.831
Synthetic Accessibility Score:  2.548
Fsp3:  0.25
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.79
MDCK Permeability:  1.9144265024806373e-05
Pgp-inhibitor:  0.915
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.005

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.055
Plasma Protein Binding (PPB):  99.62396240234375%
Volume Distribution (VD):  0.388
Pgp-substrate:  0.6496615409851074%

ADMET: Metabolism

CYP1A2-inhibitor:  0.959
CYP1A2-substrate:  0.509
CYP2C19-inhibitor:  0.938
CYP2C19-substrate:  0.111
CYP2C9-inhibitor:  0.922
CYP2C9-substrate:  0.945
CYP2D6-inhibitor:  0.947
CYP2D6-substrate:  0.878
CYP3A4-inhibitor:  0.813
CYP3A4-substrate:  0.269

ADMET: Excretion

Clearance (CL):  7.53
Half-life (T1/2):  0.678

ADMET: Toxicity

hERG Blockers:  0.127
Human Hepatotoxicity (H-HT):  0.521
Drug-inuced Liver Injury (DILI):  0.201
AMES Toxicity:  0.027
Rat Oral Acute Toxicity:  0.731
Maximum Recommended Daily Dose:  0.76
Skin Sensitization:  0.763
Carcinogencity:  0.891
Eye Corrosion:  0.003
Eye Irritation:  0.181
Respiratory Toxicity:  0.618

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC205006

Natural Product ID:  NPC205006
Common Name*:   1-(5-Hydroxy-2,2-Dimethylchromen-6-Yl)-3-(4-Hydroxyphenyl)Propan-1-One
IUPAC Name:   1-(5-hydroxy-2,2-dimethylchromen-6-yl)-3-(4-hydroxyphenyl)propan-1-one
Synonyms:  
Standard InCHIKey:  BHFVJSQVKWDKGD-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C20H20O4/c1-20(2)12-11-16-18(24-20)10-8-15(19(16)23)17(22)9-5-13-3-6-14(21)7-4-13/h3-4,6-8,10-12,21,23H,5,9H2,1-2H3
SMILES:  CC1(C)C=Cc2c(ccc(C(=O)CCc3ccc(cc3)O)c2O)O1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL185018
PubChem CID:   9973521
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003467] Linear 1,3-diarylpropanoids
        • [CHEMONTID:0001630] Chalcones and dihydrochalcones
          • [CHEMONTID:0003473] 2'-Hydroxy-dihydrochalcones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11451 Lespedeza cyrtobotrya Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[19102656]
NPO11451 Lespedeza cyrtobotrya Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO11451 Lespedeza cyrtobotrya Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO11451 Lespedeza cyrtobotrya Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO10080 Teucrium betonicum Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT633 Organism Leishmania donovani Leishmania donovani Inhibition = 89.0 % PMID[565801]
NPT2 Others Unspecified IC50 = 2000.0 nM PMID[565802]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum MIC = 30860.0 nM PMID[565803]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC205006 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC64908
1.0 High Similarity NPC118840
1.0 High Similarity NPC147688
1.0 High Similarity NPC156590
0.9926 High Similarity NPC226636
0.9926 High Similarity NPC235239
0.9926 High Similarity NPC172986
0.9926 High Similarity NPC270883
0.9926 High Similarity NPC305355
0.9926 High Similarity NPC475680
0.9926 High Similarity NPC11561
0.9926 High Similarity NPC261227
0.9854 High Similarity NPC38219
0.9853 High Similarity NPC110969
0.9853 High Similarity NPC103362
0.9852 High Similarity NPC301217
0.9852 High Similarity NPC303633
0.9852 High Similarity NPC55018
0.9852 High Similarity NPC216978
0.9852 High Similarity NPC220062
0.9852 High Similarity NPC96565
0.9783 High Similarity NPC234629
0.9783 High Similarity NPC311741
0.9781 High Similarity NPC293852
0.9781 High Similarity NPC214236
0.9781 High Similarity NPC299080
0.9781 High Similarity NPC59739
0.9781 High Similarity NPC78803
0.9781 High Similarity NPC217083
0.9781 High Similarity NPC62840
0.9781 High Similarity NPC144499
0.9779 High Similarity NPC150522
0.9779 High Similarity NPC69769
0.9779 High Similarity NPC241100
0.9779 High Similarity NPC159275
0.9778 High Similarity NPC201395
0.971 High Similarity NPC18585
0.971 High Similarity NPC166138
0.971 High Similarity NPC219915
0.971 High Similarity NPC106985
0.9708 High Similarity NPC282300
0.9706 High Similarity NPC78913
0.9706 High Similarity NPC18260
0.9706 High Similarity NPC53181
0.9706 High Similarity NPC217186
0.9643 High Similarity NPC104406
0.9643 High Similarity NPC79469
0.9643 High Similarity NPC201731
0.9643 High Similarity NPC97716
0.9643 High Similarity NPC110303
0.9643 High Similarity NPC23728
0.9643 High Similarity NPC237635
0.9643 High Similarity NPC24673
0.964 High Similarity NPC278175
0.964 High Similarity NPC257236
0.964 High Similarity NPC469953
0.964 High Similarity NPC209040
0.9638 High Similarity NPC200694
0.9632 High Similarity NPC470669
0.9632 High Similarity NPC470668
0.963 High Similarity NPC13408
0.9574 High Similarity NPC6511
0.9574 High Similarity NPC160821
0.9574 High Similarity NPC132592
0.9574 High Similarity NPC266572
0.9571 High Similarity NPC312973
0.9571 High Similarity NPC267375
0.9571 High Similarity NPC88964
0.9571 High Similarity NPC214774
0.9571 High Similarity NPC475052
0.9571 High Similarity NPC83357
0.9571 High Similarity NPC111786
0.9571 High Similarity NPC470647
0.9571 High Similarity NPC195621
0.9571 High Similarity NPC54577
0.9571 High Similarity NPC477955
0.9571 High Similarity NPC124729
0.9571 High Similarity NPC246948
0.9571 High Similarity NPC142405
0.9571 High Similarity NPC301276
0.9571 High Similarity NPC67805
0.9571 High Similarity NPC176229
0.9571 High Similarity NPC20488
0.9568 High Similarity NPC143896
0.9568 High Similarity NPC9117
0.9568 High Similarity NPC221432
0.9568 High Similarity NPC214166
0.9568 High Similarity NPC478086
0.9568 High Similarity NPC316816
0.9568 High Similarity NPC164980
0.9568 High Similarity NPC190637
0.9568 High Similarity NPC75049
0.9568 High Similarity NPC39329
0.9568 High Similarity NPC149026
0.9568 High Similarity NPC310130
0.9568 High Similarity NPC169591
0.9568 High Similarity NPC293053
0.9568 High Similarity NPC68104
0.9568 High Similarity NPC212932
0.9568 High Similarity NPC175504
0.9568 High Similarity NPC91560
0.9568 High Similarity NPC24821
0.9568 High Similarity NPC257097
0.9568 High Similarity NPC150408
0.9568 High Similarity NPC11700
0.9565 High Similarity NPC3188
0.9565 High Similarity NPC14871
0.9562 High Similarity NPC23257
0.9559 High Similarity NPC250266
0.9559 High Similarity NPC317119
0.9559 High Similarity NPC266597
0.9559 High Similarity NPC228661
0.9556 High Similarity NPC151113
0.9507 High Similarity NPC37208
0.9507 High Similarity NPC10027
0.9507 High Similarity NPC65775
0.9507 High Similarity NPC221868
0.9504 High Similarity NPC283234
0.9504 High Similarity NPC14001
0.9504 High Similarity NPC180477
0.9504 High Similarity NPC473077
0.9504 High Similarity NPC296998
0.9504 High Similarity NPC166757
0.95 High Similarity NPC473013
0.95 High Similarity NPC216538
0.95 High Similarity NPC131579
0.95 High Similarity NPC273538
0.95 High Similarity NPC319752
0.95 High Similarity NPC197252
0.95 High Similarity NPC326500
0.95 High Similarity NPC473015
0.95 High Similarity NPC236766
0.95 High Similarity NPC131568
0.9496 High Similarity NPC36181
0.9496 High Similarity NPC78
0.9496 High Similarity NPC147145
0.9496 High Similarity NPC166482
0.9496 High Similarity NPC194432
0.9496 High Similarity NPC324436
0.9496 High Similarity NPC328164
0.9496 High Similarity NPC265040
0.9496 High Similarity NPC177354
0.9496 High Similarity NPC227579
0.9496 High Similarity NPC10937
0.9496 High Similarity NPC228504
0.9496 High Similarity NPC296917
0.9496 High Similarity NPC66515
0.9496 High Similarity NPC148757
0.9496 High Similarity NPC324134
0.9496 High Similarity NPC40833
0.9496 High Similarity NPC1089
0.9496 High Similarity NPC125855
0.9496 High Similarity NPC182852
0.9496 High Similarity NPC107572
0.9496 High Similarity NPC223500
0.9496 High Similarity NPC306829
0.9496 High Similarity NPC76372
0.9496 High Similarity NPC161506
0.9496 High Similarity NPC32739
0.9496 High Similarity NPC37496
0.9496 High Similarity NPC166934
0.9496 High Similarity NPC473042
0.9496 High Similarity NPC167624
0.9496 High Similarity NPC64915
0.9496 High Similarity NPC76338
0.9496 High Similarity NPC220998
0.9493 High Similarity NPC172250
0.9493 High Similarity NPC471587
0.9493 High Similarity NPC215311
0.9493 High Similarity NPC213659
0.9493 High Similarity NPC80962
0.9493 High Similarity NPC48624
0.9493 High Similarity NPC204985
0.9493 High Similarity NPC259166
0.9493 High Similarity NPC144118
0.9493 High Similarity NPC326109
0.9493 High Similarity NPC219917
0.9489 High Similarity NPC21350
0.9489 High Similarity NPC131130
0.9489 High Similarity NPC124269
0.9489 High Similarity NPC248995
0.9489 High Similarity NPC254168
0.9489 High Similarity NPC272844
0.9485 High Similarity NPC477244
0.9485 High Similarity NPC274109
0.9485 High Similarity NPC127447
0.9485 High Similarity NPC194281
0.9485 High Similarity NPC150399
0.9485 High Similarity NPC98115
0.9485 High Similarity NPC477243
0.9485 High Similarity NPC234133
0.9485 High Similarity NPC29353
0.9485 High Similarity NPC124784
0.9485 High Similarity NPC249606
0.9485 High Similarity NPC174999
0.9485 High Similarity NPC66349
0.9485 High Similarity NPC1486
0.9485 High Similarity NPC473887
0.9485 High Similarity NPC12165
0.9485 High Similarity NPC186838

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC205006 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.964 High Similarity NPD7410 Clinical (unspecified phase)
0.95 High Similarity NPD4378 Clinical (unspecified phase)
0.9209 High Similarity NPD1549 Phase 2
0.9137 High Similarity NPD1552 Clinical (unspecified phase)
0.9137 High Similarity NPD1550 Clinical (unspecified phase)
0.913 High Similarity NPD1510 Phase 2
0.9118 High Similarity NPD1240 Approved
0.9065 High Similarity NPD2796 Approved
0.8986 High Similarity NPD1607 Approved
0.898 High Similarity NPD7411 Suspended
0.8912 High Similarity NPD4380 Phase 2
0.8859 High Similarity NPD2393 Clinical (unspecified phase)
0.8808 High Similarity NPD7075 Discontinued
0.88 High Similarity NPD8443 Clinical (unspecified phase)
0.8792 High Similarity NPD6801 Discontinued
0.8759 High Similarity NPD1511 Approved
0.8733 High Similarity NPD7096 Clinical (unspecified phase)
0.8733 High Similarity NPD7819 Suspended
0.8681 High Similarity NPD3750 Approved
0.8639 High Similarity NPD1512 Approved
0.863 High Similarity NPD6799 Approved
0.8611 High Similarity NPD7421 Clinical (unspecified phase)
0.8609 High Similarity NPD2801 Approved
0.8562 High Similarity NPD4381 Clinical (unspecified phase)
0.8543 High Similarity NPD1934 Approved
0.8497 Intermediate Similarity NPD7768 Phase 2
0.8483 Intermediate Similarity NPD2800 Approved
0.8483 Intermediate Similarity NPD1243 Approved
0.8471 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8442 Intermediate Similarity NPD3749 Approved
0.8411 Intermediate Similarity NPD6599 Discontinued
0.8377 Intermediate Similarity NPD3882 Suspended
0.8333 Intermediate Similarity NPD3748 Approved
0.8333 Intermediate Similarity NPD2799 Discontinued
0.8322 Intermediate Similarity NPD6651 Approved
0.8313 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8298 Intermediate Similarity NPD2313 Discontinued
0.8298 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8288 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.828 Intermediate Similarity NPD6959 Discontinued
0.8276 Intermediate Similarity NPD2935 Discontinued
0.8276 Intermediate Similarity NPD1551 Phase 2
0.8219 Intermediate Similarity NPD2344 Approved
0.8212 Intermediate Similarity NPD5403 Approved
0.8212 Intermediate Similarity NPD920 Approved
0.8201 Intermediate Similarity NPD1203 Approved
0.8194 Intermediate Similarity NPD3817 Phase 2
0.8188 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8137 Intermediate Similarity NPD3818 Discontinued
0.8125 Intermediate Similarity NPD6166 Phase 2
0.8125 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.811 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.8101 Intermediate Similarity NPD5494 Approved
0.8098 Intermediate Similarity NPD5953 Discontinued
0.8086 Intermediate Similarity NPD7286 Phase 2
0.8082 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8079 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8079 Intermediate Similarity NPD5401 Approved
0.8054 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.8042 Intermediate Similarity NPD3268 Approved
0.8027 Intermediate Similarity NPD6099 Approved
0.8027 Intermediate Similarity NPD6100 Approved
0.8014 Intermediate Similarity NPD2798 Approved
0.8 Intermediate Similarity NPD6232 Discontinued
0.8 Intermediate Similarity NPD2309 Approved
0.7987 Intermediate Similarity NPD3226 Approved
0.7986 Intermediate Similarity NPD9717 Approved
0.7975 Intermediate Similarity NPD7054 Approved
0.7963 Intermediate Similarity NPD7473 Discontinued
0.7961 Intermediate Similarity NPD2533 Approved
0.7961 Intermediate Similarity NPD2532 Approved
0.7961 Intermediate Similarity NPD2534 Approved
0.7959 Intermediate Similarity NPD7033 Discontinued
0.7959 Intermediate Similarity NPD4308 Phase 3
0.7943 Intermediate Similarity NPD2797 Approved
0.7939 Intermediate Similarity NPD6559 Discontinued
0.7933 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7931 Intermediate Similarity NPD943 Approved
0.7927 Intermediate Similarity NPD7074 Phase 3
0.7927 Intermediate Similarity NPD7472 Approved
0.7917 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7914 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7914 Intermediate Similarity NPD422 Phase 1
0.7911 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7902 Intermediate Similarity NPD6832 Phase 2
0.7883 Intermediate Similarity NPD1548 Phase 1
0.7879 Intermediate Similarity NPD6797 Phase 2
0.7852 Intermediate Similarity NPD2346 Discontinued
0.7848 Intermediate Similarity NPD5402 Approved
0.7831 Intermediate Similarity NPD7251 Discontinued
0.7815 Intermediate Similarity NPD4628 Phase 3
0.7812 Intermediate Similarity NPD919 Approved
0.7784 Intermediate Similarity NPD7808 Phase 3
0.7778 Intermediate Similarity NPD4908 Phase 1
0.7778 Intermediate Similarity NPD7390 Discontinued
0.7758 Intermediate Similarity NPD5844 Phase 1
0.7755 Intermediate Similarity NPD5124 Phase 1
0.7755 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD3225 Approved
0.7724 Intermediate Similarity NPD4625 Phase 3
0.7716 Intermediate Similarity NPD1247 Approved
0.7692 Intermediate Similarity NPD3267 Approved
0.7692 Intermediate Similarity NPD3266 Approved
0.7687 Intermediate Similarity NPD4307 Phase 2
0.7679 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.766 Intermediate Similarity NPD1610 Phase 2
0.7657 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD4363 Phase 3
0.7644 Intermediate Similarity NPD4360 Phase 2
0.7632 Intermediate Similarity NPD2654 Approved
0.7625 Intermediate Similarity NPD4288 Approved
0.7622 Intermediate Similarity NPD3926 Phase 2
0.7606 Intermediate Similarity NPD3972 Approved
0.7605 Intermediate Similarity NPD1729 Discontinued
0.76 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD4361 Phase 2
0.7595 Intermediate Similarity NPD6585 Discontinued
0.7562 Intermediate Similarity NPD1465 Phase 2
0.7551 Intermediate Similarity NPD1296 Phase 2
0.7551 Intermediate Similarity NPD3764 Approved
0.7547 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7517 Intermediate Similarity NPD1933 Approved
0.7516 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD9545 Approved
0.7483 Intermediate Similarity NPD1608 Approved
0.7482 Intermediate Similarity NPD9493 Approved
0.7456 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD5049 Phase 3
0.7448 Intermediate Similarity NPD1470 Approved
0.7448 Intermediate Similarity NPD1164 Approved
0.7438 Intermediate Similarity NPD5890 Approved
0.7438 Intermediate Similarity NPD5889 Approved
0.7434 Intermediate Similarity NPD5406 Approved
0.7434 Intermediate Similarity NPD5405 Approved
0.7434 Intermediate Similarity NPD5408 Approved
0.7434 Intermediate Similarity NPD5404 Approved
0.7432 Intermediate Similarity NPD411 Approved
0.7431 Intermediate Similarity NPD4749 Approved
0.7421 Intermediate Similarity NPD7458 Discontinued
0.7419 Intermediate Similarity NPD2354 Approved
0.7415 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD4287 Approved
0.7413 Intermediate Similarity NPD1201 Approved
0.7407 Intermediate Similarity NPD2296 Approved
0.74 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD447 Suspended
0.7391 Intermediate Similarity NPD1241 Discontinued
0.7386 Intermediate Similarity NPD1471 Phase 3
0.7381 Intermediate Similarity NPD5940 Clinical (unspecified phase)
0.7377 Intermediate Similarity NPD7584 Approved
0.7355 Intermediate Similarity NPD7003 Approved
0.7349 Intermediate Similarity NPD5711 Approved
0.7349 Intermediate Similarity NPD5710 Approved
0.7347 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7324 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD6798 Discontinued
0.7312 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD6104 Discontinued
0.7285 Intermediate Similarity NPD230 Phase 1
0.7279 Intermediate Similarity NPD1019 Discontinued
0.7278 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD17 Approved
0.7273 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD2353 Approved
0.7273 Intermediate Similarity NPD2355 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD7229 Phase 3
0.7241 Intermediate Similarity NPD1481 Phase 2
0.7219 Intermediate Similarity NPD1613 Approved
0.7219 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD3887 Approved
0.7181 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD6844 Discontinued
0.7178 Intermediate Similarity NPD7577 Discontinued
0.7176 Intermediate Similarity NPD3751 Discontinued
0.7176 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD1535 Discovery
0.717 Intermediate Similarity NPD4662 Approved
0.717 Intermediate Similarity NPD4661 Approved
0.716 Intermediate Similarity NPD2403 Approved
0.7143 Intermediate Similarity NPD1876 Approved
0.7134 Intermediate Similarity NPD5761 Phase 2
0.7134 Intermediate Similarity NPD5760 Phase 2
0.7126 Intermediate Similarity NPD8312 Approved
0.7126 Intermediate Similarity NPD8313 Approved
0.7115 Intermediate Similarity NPD2424 Discontinued
0.7108 Intermediate Similarity NPD6971 Discontinued
0.7107 Intermediate Similarity NPD7213 Phase 3
0.7107 Intermediate Similarity NPD7212 Phase 2
0.7105 Intermediate Similarity NPD3140 Approved
0.7105 Intermediate Similarity NPD3142 Approved
0.7102 Intermediate Similarity NPD8434 Phase 2
0.7097 Intermediate Similarity NPD4476 Approved
0.7097 Intermediate Similarity NPD4477 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data